Brief: Heron Therapeutics Announces Financial Results For The Three Months Ended June 30

Heron Therapeutics

09/08/2022 13:04

Aug 9 (Reuters) - Heron Therapeutics Inc  HRTX.O :
    * HERON THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX
MONTHS
ENDED JUNE 30, 2022 AND HIGHLIGHTS RECENT CORPORATE UPDATES
    * HERON THERAPEUTICS INC - PRO-FORMA CASH AT END OF Q2 WAS $158.7 MILLION,
WHICH
IS PROJECTED TO PROVIDE A CASH RUNWAY THROUGH 2024
    * HERON THERAPEUTICS - NET PRODUCT SALES FOR THREE MONTHS ENDED JUNE 30,
2022 WERE
$27.6 MILLION COMPARED TO $22.4 MILLION
    * HERON THERAPEUTICS INC QTRLY BASIC AND DILUTED NET LOSS PER SHARE $0.55

Source text for Eikon:  ID:nPn9KRKn4a 
Further company coverage:  HRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))